AIP-101

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAIP-101
Drug Alias NameAIP-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUltrasonography enhancers
TargetsNot applicable
Therapy Area/IndicationsDiagnostic agentsCardiomyopathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesQuadrant Healthcare
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesQuadrant Healthcare
Active IndicationsN/A
Inactive IndicationsDiagnostic agentsCardiomyopathies

Other Information

ATC CodeN/A
Related LinksN/A